FDA Investigator Jeffrey J Ebersole

Jeffrey J Ebersole has conducted inspections on 27 sites in 1 countries as of 20 Mar 2002. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
27
Last Inspection Date:
20 Mar 2002
Investigator Role:
FDA Investigation Participant
Redica ID:
100004773
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Jeffrey J Ebersole:
Addam S Reynolds, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Cramer, Ana S Cabrera, Annemarie B Randow, Annemarie Bodnar, Anthony M Criscuolo, Jr, Barbara J Maulfair, Barbara Jwilimczyk Macri, Cary Greene, Charles J Chacko, Chiang Syin, PhD, Christina N Maurino, Daniel J Grabicki, Devon Jenkins, Douglas C Kovacs, Dr. Sriram Subramaniam, PhD, Edward D Mcdonald, Emest F Bizjak, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Frederick F Razzaghi, Gayle S Lawson, Gianine E Delade, Gianine E Tompkins, Helen B Ricalde, Helen Verdel, Jason M Sluzynski, Joy Rkozlowski Klena, Juanita P Versace, Karen E D'orazio, Keith M Reilly, Kelli F Dobilas, Kerry A Kurdilla, Kristina J Donohue, Kristy A Zielny, Laishan L Lam, Lawrence R Johnson, Li Li, Lisa B Hall, Margaret M Sands, Marie T Falcone, Marjorie D Schultz, Melissa B Libby, Merril E Racke, Michael R Klapal, Nancy L Rolli, Nerizza B Guerin, Nicholas A Violand, Paul L Bellamy, Philip F Istafanos, DMV, MS, Regina T Brown, Remache, Richard H Penta, Robert G Ruff, Robert Sharpnack, Rochelle K Kimmel, Sarah Forney, Schultz, Sherri J Liu, Sinai I Davis, Susan M Halsted, Tania E Garcia, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Toyin B Oladimeji, Valerie C Reed, Willy A Orantes

Jeffrey J Ebersole's Documents

Publish Date Document Type Title
February, 2002 EIR McNeil PPC Inc. - EIR, 2002-02-05
July, 2001 FDA 483 The P.F. Laboratories Inc. - Form 483, 2001-07-06
July, 2001 EIR The P.F. Laboratories Inc. - EIR, 2001-07-06
July, 2001 FDA 483 Response The P.F. Laboratories Inc. - Form 483R, 2001-08-02
November, 2000 FDA 483 Novus Fine Chemicals - Form 483, 2000-11-27
November, 2001 EIR Frutarom USA Inc. - EIR, 2001-11-08
November, 2000 FDA 483 Response Novus Fine Chemicals - Form 483R, 2000-12-01
November, 2000 EIR Novus Fine Chemicals - EIR, 2000-11-27
April, 2001 EIR Kenwood Therapeutics - EIR, 2001-04-10
February, 2002 FDA 483 Response McNeil PPC Inc. - Form 483R, 2002-02-25
July, 2001 FDA 483 Sonar Products, Inc. - Form 483, 2001-07-31
November, 2001 FDA 483 Frutarom USA Inc. - Form 483, 2001-11-08
October, 2001 FDA 483 Response Watson Pharma, Inc. - Form 483R, 2001-12-03
March, 2002 FDA 483 Sonar Products, Inc. - Form 483, 2002-01-02
October, 2001 FDA 483 Watson Pharma, Inc. - Form 483, 2001-10-30
February, 2002 FDA 483 McNeil PPC Inc. - Form 483, 2002-02-05
August, 2001 EIR McNeil PPC Inc. - EIR, 2001-08-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more